News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Wills Robert James
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/30/2023 |
4
| Wills Robert James (Director) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 25,000 options
@ $0.3553, valued at
$8.9k
|
|
| 06/09/2023 |
4
| Wills Robert James (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Granted 30,000 options to buy
@ $3.86, valued at
$115.8k
|
|
| 01/27/2023 |
4
| Wills Robert James (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $7.8, valued at
$195k
|
|
| 10/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2022 |
4
| Wills Robert James (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Granted 30,000 options to buy
@ $6.07, valued at
$182.1k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2022 |
4
| Wills Robert James (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 67,000 options to buy
@ $2.94, valued at
$197k
|
|
| 07/29/2021 |
4
| Wills Robert James (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Granted 30,000 options to buy
@ $5.54, valued at
$166.2k
|
|
| 05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2021 |
4
| Wills Robert James (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 32,000 options to buy
@ $5.78, valued at
$185k
|
|
| 10/05/2020 |
4
| Wills Robert James (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Granted 30,000 options to buy
@ $7.1, valued at
$213k
|
|
| 10/05/2020 |
3
| Wills Robert James (Director) has filed a Form 3 on Milestone Pharmaceuticals Inc. |
| 07/31/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/31/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/12/2020 |
4
| Wills Robert James (Director) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 15,000 options
@ $2.94, valued at
$44.1k
|
|
| 05/19/2020 |
4
| Wills Robert James (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 49,245 options to buy
@ $4.05, valued at
$199.4k
|
|
| 09/16/2019 |
4
| Wills Robert James (Director) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 30,000 options
@ $5.76, valued at
$172.8k
|
|
| 01/31/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/26/2018 |
4
| Wills Robert James (Executive Chairman) has filed a Form 4 on GTX INC /DE/|
Txns:
| Bought 5,000 shares
@ $16.75, valued at
$83.8k
|
|
| 01/26/2018 |
4
| Wills Robert James (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 16,000 options to buy
@ $11.69, valued at
$187k
|
|
| 01/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/17/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/09/2016 |
4
| Wills Robert James (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Bought 25,000 shares
@ $2.4343, valued at
$60.9k
|
|
| 06/30/2016 |
4
| Wills Robert James (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 9,000 options to buy
@ $1.72, valued at
$15.5k
|
|
| 06/20/2016 |
4
| Wills Robert James (Executive Chairman) has filed a Form 4 on GTX INC /DE/|
Txns:
| Bought 100,000 shares
@ $0.6536, valued at
$65.4k
|
|
|
|